Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137

Similar articles for PubMed (Select 22592700)

1.

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

Lafuente-Lafuente C, Longas-Tejero MA, Bergmann JF, Belmin J.

Cochrane Database Syst Rev. 2012 May 16;5:CD005049. doi: 10.1002/14651858.CD005049.pub3. Review. Update in: Cochrane Database Syst Rev. 2015;3:CD005049.

PMID:
22592700
2.

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

Lafuente-Lafuente C, Mouly S, Longas-Tejero MA, Bergmann JF.

Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005049. Review. Update in: Cochrane Database Syst Rev. 2012;5:CD005049.

PMID:
17943835
3.

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

Lafuente-Lafuente C, Valembois L, Bergmann JF, Belmin J.

Cochrane Database Syst Rev. 2015 Mar 28;3:CD005049. doi: 10.1002/14651858.CD005049.pub4.

PMID:
25820938
4.

Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials.

Lafuente-Lafuente C, Mouly S, Longás-Tejero MA, Mahé I, Bergmann JF.

Arch Intern Med. 2006 Apr 10;166(7):719-28. Review.

PMID:
16606807
5.

Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.

Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J.

Am J Cardiol. 2003 Mar 20;91(6A):15D-26D. Review.

PMID:
12670638
6.

Atrial fibrillation: rate control often better than rhythm control.

[No authors listed]

Prescrire Int. 2004 Apr;13(70):64-9.

PMID:
15148984
7.

Dronedarone for the treatment of atrial fibrillation and atrial flutter.

Maund E, McKenna C, Sarowar M, Fox D, Stevenson M, Pepper C, Palmer S, Woolacott N.

Health Technol Assess. 2010 Oct;14(Suppl. 2):55-62. doi: 10.3310/hta14suppl2/08. Review.

8.

Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.

Wong CK, White HD, Wilcox RG, Criger DA, Califf RM, Topol EJ, Ohman EM.

Card Electrophysiol Rev. 2003 Sep;7(3):201-7. Review.

PMID:
14739713
9.

Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.

Bollmann A, Husser D, Cannom DS.

Am J Cardiovasc Drugs. 2005;5(6):371-8. Review.

PMID:
16259525
10.

Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.

Singh SN, Tang XC, Reda D, Singh BN.

Heart Rhythm. 2009 Feb;6(2):152-5. doi: 10.1016/j.hrthm.2008.10.036. Epub 2008 Oct 29.

PMID:
19187902
11.

Antiarrhythmic agents for atrial fibrillation: focus on prolonging atrial repolarization.

Singh BN, Mody FV, Lopez B, Sarma JS.

Am J Cardiol. 1999 Nov 4;84(9A):161R-173R. Review.

PMID:
10568677
12.

Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters.

Biffi M, Boriani G, Bartolotti M, Bacchi Reggiani L, Zannoli R, Branzi A.

Heart. 2002 May;87(5):443-8.

13.

Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.

Arsenault KA, Yusuf AM, Crystal E, Healey JS, Morillo CA, Nair GM, Whitlock RP.

Cochrane Database Syst Rev. 2013 Jan 31;1:CD003611. doi: 10.1002/14651858.CD003611.pub3. Review.

PMID:
23440790
14.

[Antiarrhythmic treatment after reduction of atrial fibrillation by external shock].

Koenig A, Theolade R, Chauvin M, Brechenmacher C.

Presse Med. 1993 Nov 20;22(36):1827-32. Review. French.

PMID:
8309912
15.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

17.

Oral antiarrhythmic drugs in converting recent onset atrial fibrillation.

Deneer VH, Borgh MB, Kingma JH, Lie-A-Huen L, Brouwers JR.

Pharm World Sci. 2004 Apr;26(2):66-78. Review.

PMID:
15085940
18.

Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a meta-analysis of clinical trials.

Miller MR, McNamara RL, Segal JB, Kim N, Robinson KA, Goodman SN, Powe NR, Bass EB.

J Fam Pract. 2000 Nov;49(11):1033-46.

PMID:
11093570
19.

[Medicamentous prevention after electric cardioversion of chronic atrial fibrillation. Goals and design of the PAFAC Study].

Fetsch T, Burschel G, Breithardt G, Engberding R, Koch HP, Lukl J, Trappe HJ, Treese N.

Z Kardiol. 1999 Mar;88(3):195-207. German.

PMID:
10355070
20.

Rate versus rhythm control in atrial fibrillation.

Wijffels MC, Crijns HJ.

Cardiol Clin. 2004 Feb;22(1):63-9. Review.

PMID:
14994848
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk